GENERAL
GlobeTech Innovation focuses on the transformation of high-potential, early-adoption stage and emerging technologies into viable business outcomes with global reach and impact.
Through collaboration with world-class universities, R&D institutions, scientists, and commercial companies, we aim to promote, foster and drive innovation as a major source of sustainable economic prosperity, competitiveness and overall wealth of society.
To us, innovation is about both development of technologies and the commercialization process - about continually seeking new applications of technologies and opening a wide range of new possibilities in markets, production, licensing, and further development. That’s what the "Innovation" in our name stands for.
With direct presences in the United States (a traditional innovation-driven economy) and the Czech Republic (a high-ranking "up-and-coming" innovation economy) and contacts around the world, we use our approach to innovation to give local ideas a global presence and to enhance innovation as a driver of social and economic prosperity.
With this focus on both social and economic prosperity, we specialize in the following key technology categories:
BIOTECHNOLOGY & CHEMISTRY
The Organisation for Economic Co-operation and Development (OECD) defines biotechnology as "the application of science and technology to living organisms, as well as parts, products and models thereof, to alter living or nonliving materials for the production of knowledge, goods and services." The European Commission specifically includes biotechnology as one of the Key Enabling Technologies, which play a vital role in driving prosperity through global competitiveness and creating dynamic knowledge-based economies capable of sustainable economic growth and highly skilled jobs. Similarly, the EC explains: "Chemistry and new sustainable chemical materials and technologies are of paramount importance… to improve the qualify of our life [for] all of us."
We see tremendous potential in biotechnology & chemistry - especially in research, development, and commercialization of innovative technologies for the prevention, diagnosis, treatment, and cure of diseases and disorders in humans, animals, and plants. This includes technologies in the following areas:
- Non-prescription drugs, therapeutics and cosmetic agents
- Diagnostics
- Medical devices
- Prescription pharmaceuticals and vaccines
- Agricultural applications (e.g., technologies to improve plant resistance)
- Industrial applications (e.g., water pollution control and abatement technologies)
HEALTHCARE
Healthcare technologies - or "biomedicine" or "biomedical technologies" - represent a very specific area of biotechnology & chemistry applications. However, because of their life-saving, social, and economic impacts, they are of such great importance that they merit separate focus.
Healthcare innovation enables development of new medical products, which help people improve their health and lead to a higher quality of life. Moreover, a healthier society decreases pressure on public healthcare expenditures and thereby can also free-up financial resources to be invested in other areas. Furthermore, in the U.S. alone, health care spending was 2.9 Trillion USD in 2013 (US Centers for Medicare and Medicaid Services).
Biomedicine specifically has shown an incredible potential for healthcare innovations. More than 50% (80% according to some sources) of European biotechnology companies are involved in health-related activities, and the medicines resulting from biotechnological innovations count for roughly 20% of all marketed medicines and represent around 50% of all new medicines in the pipeline.
Despite such great potential of healthcare technologies and their significance to societies and economies alike, healthcare innovation can be stifled by the need for highly specialized and quality human resources, the high and long-term capital intensity of healthcare development, the risks associated with sunk costs, and complex regulatory approval processes. Thus, we take an intensive, specialized, multifaceted approach to healthcare innovation.
We see the research & development and commercialization of an increasingly growing number of biomedical innovations as propelled mainly by the application of interdisciplinary approaches (especially in the areas of biology, medicine, chemistry, material, and computer sciences). For example, “the (Healthcare IT) market is forecast to exceed $24 Billion by 2015 with a CAGR of 11%. The market is expected to be driven by governments' financial incentives and regulations requiring automation in healthcare practices.” (Global Markets Direct, “The Future of the Healthcare IT Market to 2015”, Dec, 2009). Thus, GlobeTech Innovation helps institutions, universities, and businesses develop collaborative relationships with one another to address every aspect of transitioning healthcare innovation to the marketplace.
ADVANCED MATERIALS AND NANOTECHNOLOGIES
Advanced Materials - the marriage of engineering, biology, chemistry and physics know-how - stand in our focus due to their critical role in the evolution of materials science and multidisciplinary cross-industrial applications from energy and storage, through transportation to healthcare, environment, and agriculture.
We focus on both the new advanced materials themselves (e.g., polymers, composites or metals) as well as their new innovative applications (e.g., new graphene, lithium or silver applications) in a wide range of areas and disciplines like bio- and nanotechnologies research.
Nanotechnology, in particular, is a very diverse, multidisciplinary cross-cutting concept. In general terms, nanotechnology concerns controlling matter on the nanoscale and covers a wide range of R&D applications from novel approaches for the development of new materials to structures with specifically designed, unique properties. We see it as the key enabling technology being used to realize smaller, quicker, more powerful, or more “intelligent” intermediates and systems components for products with significantly improved or even completely new functions.
The valuation of the nanotechnologies market and their impact is constantly studied and analyzed. According to some of the past estimates, the nanotechnology-impacted products market was worth approximately 254 Billion USD in 2009 and is forecasted to grow to 2.5 Trillion USD in 2015, especially through development and commercialization of new industrial applications in the transportation, energy and healthcare industries.
"The global market for nanotechnology based manufactured goods will be worth US$ 1.6 Trillion in 2013, representing a forecasted CAGR of around 50% for the upcoming years."
RNCOS Industry Research Solutions, "Nanotechnology Market Forecast to 2013", Jan, 2011
GREEN ENERGY
Our Green Energy focus is on processes and technological innovations in energy generation and storage with a wide range of applications. As with other technologies in our focus, Green Energy is a field with many interdisciplinary and interconnected research domains ranging from engineering through chemistry to bio- and nanotechnologies and embedding incredible potential for global impact - both socially and economically.
Around the globe, Green Energy is viewed primarily as a means for helping countries meet their policy goals for secure, reliable, and affordable energy and to expand electricity availability, stability, and promotion of sustainable growth. For GlobeTech Innovation, it’s also closely linked with research & development and commercialization of these technologies for various applications in the transportation and electromobility industries.
We see especially strong potential in the emerging solar power technologies and the disruptive “future” batteries.